ADPGK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.992000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.415400E-01
Normal-vs-Stage2
3.170600E-01
Normal-vs-Stage3
7.420100E-02
Normal-vs-Stage4
1.648360E-01
Stage1-vs-Stage2
2.117600E-01
Stage1-vs-Stage3
2.026600E-01
Stage1-vs-Stage4
4.247800E-01
Stage2-vs-Stage3
4.691700E-02
Stage2-vs-Stage4
7.065000E-01
Stage3-vs-Stage4
1.717640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.035200E-01
Normal-vs-AfricanAmerican
2.579400E-01
Normal-vs-Asian
2.765200E-01
Caucasian-vs-AfricanAmerican
4.227800E-01
Caucasian-vs-Asian
5.085600E-01
AfricanAmerican-vs-Asian
7.813200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.912200E-01
Normal-vs-Female
3.108200E-01
Male-vs-Female
4.383200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.399000E-01
Normal-vs-Age(41-60Yrs)
3.485600E-01
Normal-vs-Age(61-80Yrs)
2.747600E-01
Normal-vs-Age(81-100Yrs)
3.407400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.419600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.497200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.599400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.059900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.930200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.630000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.937400E-01
Normal-vs-Daily Drinker
2.856000E-01
Normal-vs-Weekly Drinker
4.399700E-02
Normal-vs-Occasional Drinker
2.828000E-01
Normal-vs-Social Drinker
2.992200E-01
Non Drinker-vs-Daily Drinker
8.446600E-01
Non Drinker-vs-Weekly Drinker
8.127400E-01
Non Drinker-vs-Occasional Drinker
8.132600E-01
Non Drinker-vs-Social Drinker
9.051800E-01
Daily Drinker-vs-Weekly Drinker
7.169800E-01
Daily Drinker-vs-Occasional Drinker
9.772000E-01
Daily Drinker-vs-Social Drinker
7.715800E-01
Weekly Drinker-vs-Occasional Drinker
6.747200E-01
Weekly Drinker-vs-Social Drinker
8.944800E-01
Occasional Drinker-vs-Social Drinker
7.036600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.892800E-01
Normal-vs-Grade 2
9.919400E-01
Normal-vs-Grade 3
9.947200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.398100E-02
Grade 1-vs-Grade 3
4.783600E-02
Grade 1-vs-Grade 4
8.892800E-01
Grade 2-vs-Grade 3
9.319800E-01
Grade 2-vs-Grade 4
9.919400E-01
Grade 3-vs-Grade 4
9.947200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.989400E-01
Normal-vs-NonDiabetic
2.892000E-01
Diabetic-vs-NonDiabetic
8.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.504200E-01
Normal-vs-NoPancreatitis
2.897400E-01
Pancreatitis-vs-NoPancreatitis
2.740200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.835200E-01
Normal-vs-N1
3.143600E-01
N0-vs-N1
2.433400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.095800E-01
Normal-vs-TP53-NonMutant
1.695630E-01
TP53-Mutant-vs-TP53-NonMutant
1.019450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
